NCT00325936View on ClinicalTrials.gov

The Effects of Cilnidipine on Metabolic Syndrome Improvement

PHASE4CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
HypertensionMetabolic Syndrome X
Interventions
DRUG

Cilnidipine

10\~20mg, qd, po for 3 months or 12 months.

Trial Locations (1)

100-380

Cheil general hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT00325936 - The Effects of Cilnidipine on Metabolic Syndrome Improvement | Biotech Hunter | Biotech Hunter